SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Biomarkers for dementia: too soon for routine clinical use.

Isaacs, JD; Boenink, M (2020) Biomarkers for dementia: too soon for routine clinical use. Lancet Neurol, 19 (11). pp. 884-885. ISSN 1474-4465 https://doi.org/10.1016/S1474-4422(20)30365-3
SGUL Authors: Isaacs, Jeremy

[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (25kB)
Item Type: Article
Additional Information: © 2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Keywords: Alzheimer Disease, Amyloidosis, Biomarkers, Dementia, Fluorodeoxyglucose F18, Humans, Humans, Dementia, Alzheimer Disease, Amyloidosis, Fluorodeoxyglucose F18, Biomarkers, 1103 Clinical Sciences, 1109 Neurosciences, Neurology & Neurosurgery
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Lancet Neurol
ISSN: 1474-4465
Language: eng
Dates:
DateEvent
November 2020Published
21 October 2020Published Online
24 September 2020Accepted
PubMed ID: 33098787
Web of Science ID: WOS:000581121200007
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116099
Publisher's version: https://doi.org/10.1016/S1474-4422(20)30365-3

Statistics

Item downloaded times since 15 Feb 2024.

Actions (login required)

Edit Item Edit Item